A Phase 2a study evaluating BIVV020 in adults with persistent/chronic immune thrombocytopenia (ITP)

Trial Identifier: PDY16894
Sponsor: Bioverativ, a Sanofi company
Start Date: February 2021
Primary Completion Date: February 2022
Study Completion Date: February 2023
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Czechia Ostrava - Poruba, Czechia, 70852
Germany Essen, Germany, 45147
Netherlands Leiden, Netherlands, 2333 ZA
Spain, A Coruña [La Coruña] La Coruña, A Coruña [La Coruña], Spain, 15006
Spain, Not Known Palma de Mallorca, Not Known, Spain, 07120
Spain, Sevilla Sevilla, Spain, 41013
United Kingdom, London, City of London, London, City of, United Kingdom, W12 0HS
United States, District of Columbia Washington, District of Columbia, United States, 20007
United States, Florida Tamarac, Florida, United States, 33321